Clinical Trial Update: INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intratumoral INT230-6 in breast cancer (INVINCIBLE trial) with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• INT230-6

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN